Published date: 30 July 2021
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Vaccines for veterinary medicine - 33651690
Location of contract
SW1P 3JR
Value of contract
£2,000,000
Procurement reference
tender_259793/983927
Published date
30 July 2021
Closing date
29 September 2021
Closing time
12pm
Contract start date
22 November 2021
Contract end date
21 November 2026
Contract type
Service contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
The Authority on behalf the APHA is looking to appoint a Contract Manufacturing Organisation (CMO) to produce the fusion protein (DST-F) to the standards of UK Good Manufacturing Practice (GMP).This will involve technology transfer from the current non-GMP manufacturer of the manufacturing steps and quality control tests for all stages of production from Master Seed (MS) through to testing and release of a finished commercial product. The CMO will have the capacity for the anticipated commercial scale manufacture of up to one million doses annually
More information
Links
-
- https://defra.bravosolution.co.uk/esop/guest/go/opportunity/detail?opportunityId=50269
- Tender notice
- Link to opportunity
Additional text
-
The Authority on behalf the APHA is looking to appoint a Contract Manufacturing Organisation (CMO) to produce the fusion protein (DST-F) to the standards of UK Good Manufacturing Practice (GMP).This will involve technology transfer from the current non-GMP manufacturer of the manufacturing steps and quality control tests for all stages of production from Master Seed (MS) through to testing and release of a finished commercial product. The CMO will have the capacity for the anticipated commercial scale manufacture of up to one million doses annually
About the buyer
Address
17 Nobel House
London
SW1P 3JR
England
Telephone
+442072385921
Share this notice
Closing: 29 September 2021, 12pm